297 related articles for article (PubMed ID: 24548884)
21. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
22. FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors.
Marian C; Ochs-Balcom HM; Nie J; Kallakury BV; Ambrosone CB; Trevisan M; Edge S; Shields PG; Freudenheim JL
Int J Cancer; 2011 Aug; 129(3):702-12. PubMed ID: 20853316
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
Palomba G; Loi A; Porcu E; Cossu A; Zara I; Budroni M; Dei M; Lai S; Mulas A; Olmeo N; Ionta MT; Atzori F; Cuccuru G; Pitzalis M; Zoledziewska M; Olla N; Lovicu M; Pisano M; Abecasis GR; Uda M; Tanda F; Michailidou K; Easton DF; Chanock SJ; Hoover RN; Hunter DJ; Schlessinger D; Sanna S; Crisponi L; Palmieri G
BMC Cancer; 2015 May; 15():383. PubMed ID: 25956309
[TBL] [Abstract][Full Text] [Related]
24. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
25. FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer.
Moes-Sosnowska J; Skupinska M; Lechowicz U; Szczepulska-Wojcik E; Skronska P; Rozy A; Stepniewska A; Langfort R; Rudzinski P; Orlowski T; Popiel D; Stanczak A; Wieczorek M; Chorostowska-Wynimko J
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142417
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
[TBL] [Abstract][Full Text] [Related]
27. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
Gaudet MM; Kirchhoff T; Green T; Vijai J; Korn JM; Guiducci C; Segrè AV; McGee K; McGuffog L; Kartsonaki C; Morrison J; Healey S; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Gauthier-Villars M; Sobol H; Longy M; Frenay M; GEMO Study Collaborators ; Hogervorst FB; Rookus MA; Collée JM; Hoogerbrugge N; van Roozendaal KE; ; Piedmonte M; Rubinstein W; Nerenstone S; Van Le L; Blank SV; Caldés T; de la Hoya M; Nevanlinna H; Aittomäki K; Lazaro C; Blanco I; Arason A; Johannsson OT; Barkardottir RB; Devilee P; Olopade OI; Neuhausen SL; Wang X; Fredericksen ZS; Peterlongo P; Manoukian S; Barile M; Viel A; Radice P; Phelan CM; Narod S; Rennert G; Lejbkowicz F; Flugelman A; Andrulis IL; Glendon G; Ozcelik H; ; Toland AE; Montagna M; D'Andrea E; Friedman E; Laitman Y; Borg A; Beattie M; Ramus SJ; Domchek SM; Nathanson KL; Rebbeck T; Spurdle AB; Chen X; Holland H; ; John EM; Hopper JL; Buys SS; Daly MB; Southey MC; Terry MB; Tung N; Overeem Hansen TV; Nielsen FC; Greene MH; Mai PL; Osorio A; Durán M; Andres R; Benítez J; Weitzel JN; Garber J; Hamann U; ; Peock S; Cook M; Oliver C; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Walker L; Eason J; Barwell J; Godwin AK; Schmutzler RK; Wappenschmidt B; Engert S; Arnold N; Gadzicki D; Dean M; Gold B; Klein RJ; Couch FJ; Chenevix-Trench G; Easton DF; Daly MJ; Antoniou AC; Altshuler DM; Offit K
PLoS Genet; 2010 Oct; 6(10):e1001183. PubMed ID: 21060860
[TBL] [Abstract][Full Text] [Related]
28. A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.
Elgazzar S; Zembutsu H; Takahashi A; Kubo M; Aki F; Hirata K; Takatsuka Y; Okazaki M; Ohsumi S; Yamakawa T; Sasa M; Katagiri T; Miki Y; Nakamura Y
J Hum Genet; 2012 Dec; 57(12):766-71. PubMed ID: 22951594
[TBL] [Abstract][Full Text] [Related]
29. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
Fu F; Wang C; Huang M; Song C; Lin S; Huang H
Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
[TBL] [Abstract][Full Text] [Related]
31. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.
Prentice RL; Huang Y; Hinds DA; Peters U; Pettinger M; Cox DR; Beilharz E; Chlebowski RT; Rossouw JE; Caan B; Ballinger DG
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3079-85. PubMed ID: 19861516
[TBL] [Abstract][Full Text] [Related]
32. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
Jia C; Cai Y; Ma Y; Fu D
Breast Cancer Res Treat; 2010 Nov; 124(2):521-8. PubMed ID: 20364400
[TBL] [Abstract][Full Text] [Related]
33. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
[TBL] [Abstract][Full Text] [Related]
34. Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and FGFR3 in families with BRCA1/2-negative breast cancer.
Bergman A; Sahlin P; Emanuelsson M; Carén H; Tarnow P; Martinsson T; Grönberg H; Stenman G
Scand J Plast Reconstr Surg Hand Surg; 2009; 43(5):251-5. PubMed ID: 19863427
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of FGFR2 gene polymorphism in women with breast cancer.
Salehi Z; Afzali S; Shabanipour S; Rahimi A
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):94-7. PubMed ID: 26025410
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide association study identifies novel breast cancer susceptibility loci.
Easton DF; Pooley KA; Dunning AM; Pharoah PD; Thompson D; Ballinger DG; Struewing JP; Morrison J; Field H; Luben R; Wareham N; Ahmed S; Healey CS; Bowman R; ; Meyer KB; Haiman CA; Kolonel LK; Henderson BE; Le Marchand L; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Eccles D; Evans DG; Peto J; Fletcher O; Johnson N; Seal S; Stratton MR; Rahman N; Chenevix-Trench G; Bojesen SE; Nordestgaard BG; Axelsson CK; Garcia-Closas M; Brinton L; Chanock S; Lissowska J; Peplonska B; Nevanlinna H; Fagerholm R; Eerola H; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Cox DG; Hall P; Wedren S; Liu J; Low YL; Bogdanova N; Schürmann P; Dörk T; Tollenaar RA; Jacobi CE; Devilee P; Klijn JG; Sigurdson AJ; Doody MM; Alexander BH; Zhang J; Cox A; Brock IW; MacPherson G; Reed MW; Couch FJ; Goode EL; Olson JE; Meijers-Heijboer H; van den Ouweland A; Uitterlinden A; Rivadeneira F; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Hopper JL; McCredie M; Southey M; Giles GG; Schroen C; Justenhoven C; Brauch H; Hamann U; Ko YD; Spurdle AB; Beesley J; Chen X; ; ; Mannermaa A; Kosma VM; Kataja V; Hartikainen J; Day NE; Cox DR; Ponder BA
Nature; 2007 Jun; 447(7148):1087-93. PubMed ID: 17529967
[TBL] [Abstract][Full Text] [Related]
37. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
Chen Y; Shi C; Guo Q
World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
[TBL] [Abstract][Full Text] [Related]
38. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Slattery ML; John EM; Stern MC; Herrick J; Lundgreen A; Giuliano AR; Hines L; Baumgartner KB; Torres-Mejia G; Wolff RK
Breast Cancer Res Treat; 2013 Aug; 140(3):587-601. PubMed ID: 23912956
[TBL] [Abstract][Full Text] [Related]
39. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan.
Kawase T; Matsuo K; Suzuki T; Hiraki A; Watanabe M; Iwata H; Tanaka H; Tajima K
Int J Cancer; 2009 Oct; 125(8):1946-52. PubMed ID: 19582883
[TBL] [Abstract][Full Text] [Related]
40. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
